Jian H. Johnson

1.5k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Jian H. Johnson is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Jian H. Johnson has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Jian H. Johnson's work include Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Jian H. Johnson is often cited by papers focused on Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Jian H. Johnson collaborates with scholars based in United States, United Kingdom and Czechia. Jian H. Johnson's co-authors include K. Griffiths, J. L. Haybittle, F C Campbell, Robert I. Nicholson, C.W. Elston, R.W. Blamey, Bruce L. Brown, Martha S. Hearron, C.W. Elston and R.W. Blamey and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Bacteriology.

In The Last Decade

Jian H. Johnson

16 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A prognostic index in primary breast cancer

1982 527 citations J. L. Haybittle, R.W. Blamey et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Jian H. Johnson

Since Specialization

Citations

This map shows the geographic impact of Jian H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian H. Johnson more than expected).

Fields of papers citing papers by Jian H. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian H. Johnson. The network helps show where Jian H. Johnson may publish in the future.

Co-authorship network of co-authors of Jian H. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Jian H. Johnson. A scholar is included among the top collaborators of Jian H. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian H. Johnson. Jian H. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Genome Sequence of the Marine Photoheterotrophic Bacterium Erythrobacter sp. Strain NAP1 2011 ·Journal of Bacteriology ·Michal Koblížek, Jan Janouškovec, Miroslav Obornı́k, Jian H. Johnson, Steve Ferriera, Paul G. Falkowski	22
2	A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses 1999 ·Archives of Internal Medicine ·Mark Crowther, (unknown), Clive Kearon, Linda Harrison, Jian H. Johnson, M. Patricia Massicotte, Jack Hirsh	136
3	Dynorphin A(1-13) Analgesia in Opioid-Treated Patients with Chronic Pain 1999 ·Clinical Drug Investigation ·Russell K. Portenoy, Augusto Caraceni, Nathan I. Cherny, Ronald Goldblum, Jane Ingham, Charles E. Inturrisi, Jian H. Johnson, Jeanne Lapin, Paul J. Tiseo, Mary Jeanne Kreek	11
4	Clinical Safety of Flurbiprofen 1990 ·The Journal of Clinical Pharmacology ·Carter D. Brooks, Otto I. Linet, Diana Schellenberg, (unknown), (unknown), (unknown), Jian H. Johnson, Joseph R. Assenzo	13
5	Comparison of two dosing schedules of flurbiprofen for patients with rheumatoid arthritis: Twice-daily versus four-times-a-day schedules 1986 ·The American Journal of Medicine ·Bruce L. Brown, (unknown), Martha S. Hearron, Jian H. Johnson	8
6	Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis 1986 ·The American Journal of Medicine ·Bruce L. Brown, Jian H. Johnson, Martha S. Hearron	100
7	Flurbiprofen versus naproxen in the treatment of rheumatoid arthritis 1986 ·The American Journal of Medicine ·Bruce L. Brown, Jian H. Johnson, (unknown)	10
8	Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer 1983 ·British Journal of Cancer ·C J Mumford, C.W. Elston, F C Campbell, R.W. Blamey, Jian H. Johnson, Robert I. Nicholson, K. Griffiths	6
9	A prognostic index in primary breast cancer breakdown → 1982 ·British Journal of Cancer ·J. L. Haybittle, R.W. Blamey, C.W. Elston, Jian H. Johnson, (unknown), F C Campbell, Robert I. Nicholson, K. Griffiths	527
10	The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma. 1980 ·PubMed ·(unknown), RW Blamey, Jian H. Johnson, (unknown), (unknown), Kate Griffiths	14
11	Prognostic factors in breast cancer -- the formation of a prognostic index. 1979 ·PubMed ·R.W. Blamey, C J Davies, C.W. Elston, Jian H. Johnson, J. L. Haybittle, Paul V. Maynard	61
12	Relationship between oestrogen-receptor content and histological grade in human primary breast tumours 1978 ·British Journal of Cancer ·Paul V. Maynard, (unknown), R.W. Blamey, C.W. Elston, Jian H. Johnson, K. Griffiths	108
13	Structure of nogalamycin 1977 ·Journal of the American Chemical Society ·Paul F. Wiley, R. B. Kelly, E. Louis Caron, (unknown), Jian H. Johnson, Forrest A. MacKellar, S. A. MIZSAK	69
14	Reductive microbial conversion of anthracycline antibiotics 1976 ·Biochemistry ·V. P. MARSHALL, (unknown), L. M. Reineke, Jian H. Johnson, Paul F. Wiley	29
15	Alkyl and acyl derivatives of tubercidin. 1976 ·The Journal of Antibiotics ·Paul F. Wiley, Jian H. Johnson, A. R. Hanze	2
16	Production of a new thermostable neutral α‐galactosidase from a strain of Bacillus stearothermophilus 1974 ·Biotechnology and Bioengineering ·Jacques Delente, Jian H. Johnson, (unknown), Richard J. O’Connor, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact